Health

Chairman:  Joe Pitts (PA-16)
Jurisdiction: 
Public health and quarantine; hospital construction; mental health; biomedical research and development; health information technology, privacy, and cybersecurity; public health insurance (Medicare, Medicaid) and private health insurance; medical malpractice and medical malpractice insurance; the regulation of food, drugs, and cosmetics; drug abuse; the Department of Health and Human Services; the National Institutes of Health; the Centers for Disease Control; Indian Health Service; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.

Members

Republicans

Chairman: Joe Pitts (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Ed Whitfield (KY)
John Shimkus (IL)
Mike Rogers (MI)
Tim Murphy (PA)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Cathy McMorris Rodgers (WA)
Leonard Lance (NJ)
Bill Cassidy (LA)
Brett Guthrie (KY)
Morgan Griffith (VA)
Gus Bilirakis (FL)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)

Democrats

Ranking Member: Frank Pallone, Jr. (NJ)
John D. Dingell (MI)
Eliot L. Engel (NY)
Lois Capps (CA)
Jan Schakowsky (IL)
Jim Matheson (UT)
Gene Green (TX)
G.K. Butterfield (NC)
John Barrow (GA)
Donna M. Christensen (VI)
Kathy Castor (FL)
John Sarbanes (MD)
Henry A. Waxman (CA)

October 1, 2013 | ICYMI

October 1, 2013

By Chairmen Fred Upton (R-MI), Dave Camp (R-MI), and John Kline (R-MN)

>>
September 30, 2013 | Blog Post

The Obama administration’s signature health law is scheduled to officially launch tomorrow, but it appears the delays and missed deadlines that have plagued implementation will continue.

>>
September 28, 2013 | Press Release

WASHINGTON, DC – The House of Representatives today passed H.R. 3204, the Drug Quality and Security Act, by a voice vote.

>>
September 28, 2013 | Press Release

WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) today kicked off debate on the bipartisan H.R. 3204, the Drug Quality and Security Act.

>>
September 27, 2013 | Fact Sheet

The Drug Quality and Security Act would address two important issues affecting the quality and security of America’s drug supply. First, the bill would protect traditional pharmacies and clarify laws related to human drug compounding in response to the nationwide meningitis outbreak – one of the largest public health crises in recent memory.

>>
September 27, 2013 | Press Release

WASHINGTON, DC – The House Committee on Energy and Commerce today announced its hearing schedule for the week of September 30, 2013.

>>

Pages